Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Newsroom
At Memorial Sloan Kettering Cancer Center, our world-renowned cancer researchers, oncologists, clinicians, and scientists are constantly advancing our knowledge about cancer. Our discoveries are improving treatment and care for patients here and all over the world. On this page, you will find news & information about our latest groundbreaking cancer science, exceptional patient care and the dedicated professionals who make it all happen.
For Journalists
Connect with us to reach MSK experts for media inquiries and for story ideas.
Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the best cancer center in the northeast, the number two hospital for cancer care in the nation, and the number one hospital nationally for urology care by U.S. News & World Report in its annual Best Hospitals listing.
Over the last seven and a half decades, researchers at the Sloan Kettering Institute have made important contributions to the fundamental understanding of human biology, as well as driven practice-changing innovations in the treatment of cancer.
The program, established through a $25 million grant from the Stavros Niarchos Foundation (SNF) as part of its Global Health Initiative, aims to improve outcomes for pediatric cancer patients through international healthcare collaborations.
Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, May 31–June 4, in Chicago.
Learn why over 2000 people travel from all over the country for cancer care at Memorial Sloan Kettering each year, including resources for the specific needs of traveling patients and their loved ones.
In a plenary presentation at the 2024 American Association for Cancer Research (AACR) Annual Meeting, Dr. Dana Pe’er highlighted three recent research collaborations between her lab and other labs at MSK that have shed new light on the ability of cancer cells to adapt and spread.
When Dennis Flaherty was diagnosed with stage 4 kidney cancer, he knew he wanted to be treated at MSK. His story illustrates why U.S. News & World Report ranked MSK the top hospital in the country for urology care in 2023.
Cancer Straight Talk brings together national experts and cancer patients to have straightforward, evidence-based conversations. Medical oncologist Diane Reidy-Lagunes hosts this series with the mission of educating and empowering patients to make the right decisions and live happier, healthier lives.
